Radio pharmaceuticals are drugs that contain radioactive isotopes that emit radiation that can be detected by imaging technology such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma cameras.
Radio pharmaceuticals are used in diagnostic imaging procedures to detect different diseases and conditions such as cancer, heart disease, and neurological disorders. They are also used in therapeutic procedures to treat cancer and other conditions.
Radio pharmaceuticals can be classified into two types: diagnostic and therapeutic. Diagnostic radio pharmaceuticals are used to produce images of the body to identify specific conditions or diseases. Therapeutic radio pharmaceuticals are used to deliver radiation therapy to tumors or cancer cells.
Radio pharmaceuticals are typically administered as injections, oral solutions, or inhalants. The dose of radiation received by the patient is usually very low and poses no significant health risks.
The production and use of radio pharmaceuticals are highly regulated by national and international bodies such as the International Atomic Energy Agency (IAEA) and the United States Nuclear Regulatory Commission (NRC).
Overall, radio pharmaceuticals have proven to be an effective and safe tool in the diagnosis and treatment of various diseases and conditions.